This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

W. Rex Hawkins, MD
Houston, Tex

Arch Ophthalmol. 1991;109(10):1345.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—In recent months, readers have noticed that Lederle Laboratories and Storz Ophthalmics Inc, in a joint effort, have begun placing zinc supplementation advertisements in the ARCHIVES and one other ophthalmologic journal, Retina. Earlier, the same two companies distributed tablet packets and advertising brochures to ophthalmologists nationwide. The information in those brochures was substantiated by several references, foremost of which was the article by Newsome et al¹ in the February 1988 issue of the ARCHIVES.

Review of that article reveals some data inconsistencies that the authors will not mind clarifying, I trust, even at this late time. In Table 5, they note that two eyes in the zinc-treated group sustained a visual loss of 20 letters or more, and that five eyes in the placebo group suffered the same loss. The first paragraph in the "Visual Acuity Outcomes" section reiterates that same data.

In the next section, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?